MSA
WST icon

Marino Stram & Associates’s West Pharmaceutical WST Stock Holding History

Marino Stram & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,091
Closed -$392K – 293
2021
Q2 		$392K Buy
+1,091
New +$360K 0.1% 157

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marino Stram & Associates's WST Position: Q3 2021 in Review

Marino Stram & Associates sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 1,091 shares — an estimated $392K sold.

Marino Stram & Associates first reported a position in WST in Q2 2021 and held it in 1 quarter. The position peaked at $392K in Q2 2021. 669 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Marino Stram & Associates reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Marino Stram & Associates sold 1,091 West Pharmaceutical shares in Q3 2021, an estimated $392K.
  • Marino Stram & Associates first reported a position in West Pharmaceutical in Q2 2021 and held it in 1 quarter.
  • Marino Stram & Associates's West Pharmaceutical position peaked at $392K in Q2 2021.
  • 669 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Marino Stram & Associates's 13F filing for Q3 2021, filed 14 Oct 2021.